Abstract |
Genetic polymorphism of the serotonin 5-HT(2A) receptor seems to be associated with therapeutic response to selective serotonin reuptake inhibitors ( SSRIs). The present study investigated whether a novel -1438G/A polymorphism in the promoter region of the 5-HT(2A )receptor gene is associated with therapeutic response to fluvoxamine (an SSRI) in 66 Japanese patients with major depressive disorder. Fluvoxamine (50 to 200 mg) was administered twice daily for 6 weeks. Fifty-four patients completed this study. The genotype distribution and the allele frequencies showed no significant difference between responders and non-responders. The time-course of the Montgomery-Asberg Depression Rating Scale scores showed no significant difference among -1438G/G, -1438G/A, and -1438A/A genotype groups. The results demonstrated that the -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene was unlikely to have a major role in therapeutic response to fluvoxamine in Japanese patients with major depressive disorder.
|
Authors | Kazuhiro Sato, Keizo Yoshida, Hitoshi Takahashi, Kenichi Ito, Mitsuhiro Kamata, Hisashi Higuchi, Tetsuo Shimizu, Kunihiko Itoh, Kazuyuki Inoue, Takehiko Tezuka, Toshio Suzuki, Taashi Ohkubo, Kazunobu Sugawara, Koichi Otani |
Journal | Neuropsychobiology
(Neuropsychobiology)
Vol. 46
Issue 3
Pg. 136-40
( 2002)
ISSN: 0302-282X [Print] Switzerland |
PMID | 12422060
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2002 S. Karger AG, Basel |
Chemical References |
- Receptor, Serotonin, 5-HT2A
- Receptors, Serotonin
- Serotonin Uptake Inhibitors
- Fluvoxamine
|
Topics |
- Adult
- Aged
- Chi-Square Distribution
- Depressive Disorder, Major
(drug therapy, genetics)
- Dose-Response Relationship, Drug
- Female
- Fluvoxamine
(blood, therapeutic use)
- Gene Frequency
- Genotype
- Humans
- Japan
- Male
- Middle Aged
- Polymorphism, Single Nucleotide
- Promoter Regions, Genetic
(genetics)
- Psychiatric Status Rating Scales
- Receptor, Serotonin, 5-HT2A
- Receptors, Serotonin
(genetics)
- Selective Serotonin Reuptake Inhibitors
(blood, therapeutic use)
- Time Factors
- Treatment Outcome
|